ID: ALA2323724

Max Phase: Preclinical

Molecular Formula: C21H24O6

Molecular Weight: 372.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(CCC(=O)/C=C(\O)CCc2ccc(O)c(OC)c2)ccc1O

Standard InChI:  InChI=1S/C21H24O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h5-6,9-13,22,24-25H,3-4,7-8H2,1-2H3/b16-13-

Standard InChI Key:  PNTMRHGYQCMNCZ-SSZFMOIBSA-N

Associated Targets(Human)

Retinoic acid receptor 39 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Retinoid X receptor 114 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glucocorticoid receptor 14987 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vitamin D receptor 26531 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-secretase 1 15641 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 372.42Molecular Weight (Monoisotopic): 372.1573AlogP: 3.69#Rotatable Bonds: 9
Polar Surface Area: 96.22Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.89CX Basic pKa: CX LogP: 3.80CX LogD: 3.79
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.46Np Likeness Score: 0.72

References

1. Batie S, Lee JH, Jama RA, Browder DO, Montano LA, Huynh CC, Marcus LM, Tsosie DG, Mohammed Z, Trang V, Marshall PA, Jurutka PW, Wagner CE..  (2013)  Synthesis and biological evaluation of halogenated curcumin analogs as potential nuclear receptor selective agonists.,  21  (3): [PMID:23276449] [10.1016/j.bmc.2012.11.033]
2. Konno H, Endo H, Ise S, Miyazaki K, Aoki H, Sanjoh A, Kobayashi K, Hattori Y, Akaji K..  (2014)  Synthesis and evaluation of curcumin derivatives toward an inhibitor of beta-site amyloid precursor protein cleaving enzyme 1.,  24  (2): [PMID:24360557] [10.1016/j.bmcl.2013.11.039]

Source